Questions | Responses – n (%) |
---|---|
1. Did you receive information about the ototoxic effects of the chemotherapy medication before commencing with treatment? | No – 33 (41.3) |
Yes – 47 (58.8) | |
2. Who provided you with the information? | Nurse – 3 (6.4%) |
Oncologist /clinician– 36 (76.6) | |
Audiologist – 7 (14.9) | |
Pharmacist – 0 | |
Radiotherapist – 1 (2.1) | |
3. Who referred you for ototoxicity monitoring? | Nurse – 3 (3.8) |
Oncologist/clinician – 32 (40.0) | |
Pharmacist – 1 (1.3) Audiologist – 40 (50) | |
Radiotherapist – 4 (5) | |
4. Were the audiological evaluations conducted on the same day as your chemotherapy? | No – 53 (66.3) |
Yes – 6 (7.5) | |
Sometimes – 21 (26.3) | |
5. Do you feel that the duration of the audiological testing was too long? | No – 38 (47.5) |
Yes – 42 (52.5) | |
6. Were the results of the audiological evaluations clearly explained to you? | No - 0 (0) |
Yes – 80 (100.0) | |
7. Which of the following recommendations were made? | Hearing aid evaluation – 3 (3.8) |
Counselling – 46 (57.5) | |
Tinnitus management – 3 (3.8) | |
Combination of all - 5 (6.3) | |
Hearing aid evaluation and counselling – 4 (5.0) | |
Hearing aid evaluation and tinnitus management – 19 (23.8) | |
8. Did you follow-up on any of the above recommendations made? | No -1 (1.3) |
Yes – 76 (95.0) | |
Sometimes – 3 (3.8) | |
9. Do you feel that the monitoring of your hearing during chemotherapy was beneficial | No – 3 (3.8) |
Yes – 71 (88.8) | |
Do not know – 6 (7.5) |